Lipopolysaccharide endotoxemia induces amyloid-β and p-tau formation in the rat brain.

Liming Wang, Qi Wu, Ryan A. Kirk, Kevin P. Horn, Ahmed Ebada Salem, John M. Hoffman, Jeffrey T. Yap, Joshua A. Sonnen, Rheal A. Towner, Fernando A. Bozza, Rosana Souza Rodrigues, Kathryn A. MortonPubMed 2018

TL;DR

This study demonstrates that a single dose of lipopolysaccharide (LPS), a component of bacterial cell walls that mimics sepsis, triggers neuroinflammation in rats, leading to the formation of amyloid-beta (Aβ) plaques and the accumulation of phosphorylated tau (p-tau) in the brain. These findings suggest a potential mechanistic link between systemic inflammation, like that seen in sepsis, and the neuropathological hallmarks of Alzheimer's disease.

What Problem Does This Paper Address?

Alzheimer's disease (AD) is characterized by the accumulation of amyloid-beta (Aβ) plaques and hyperphosphorylated tau (p-tau) in the brain, leading to cognitive decline. While Aβ plaques are not exclusive to AD and can be found in aging individuals, the precise mechanisms driving their formation, especially in the context of systemic insults, are not fully understood. Sepsis, a severe systemic inflammatory condition, is known to cause neurocognitive dysfunction. This paper investigates whether the acute systemic inflammation induced by sepsis (modeled using LPS) can directly trigger the cascade of events leading to Aβ and p-tau pathology in the brain, thereby providing a potential link between systemic inflammation and AD-like neuropathology.

Methods

The researchers used a rat model of endotoxemia, administering a single intraperitoneal injection of lipopolysaccharide (LPS) to male Sprague Dawley rats. They then assessed various biological markers at different time points post-injection (from 2 hours to 7-9 days). Key methods included:

  • Cytokine Measurement: ELISA was used to quantify levels of inflammatory cytokines (IL-1β, IL-6, TNFα) in both plasma and brain homogenates.
  • Microglial Density: Immunohistochemistry with Iba-1 staining was employed to assess the density of microglia, a key indicator of neuroinflammation, in the cerebral cortex.
  • Aβ and p-tau Quantification: Western blotting was used to measure the levels of soluble Aβ (1-42) monomer and phosphorylated tau (p-tau) in whole brain homogenates.
  • Aβ Plaque Characterization: Immunohistochemistry for Aβ plaques was performed on brain sections, followed by confocal microscopy to characterize their morphology and co-localization with other markers (microglia, IL-1β, C3, ApoE).
  • PET Tracer Uptake: Autoradiography using the PET tracer [<sup>18</sup>F]flutemetamol was conducted to assess Aβ plaque burden in the brain.

Datasets

Not discussed in the paper. The study utilized experimental animal models and their biological samples.

Key Insights and Ideas

  • Sepsis as a Trigger for AD-like Pathology: The most striking insight is that a single, acute systemic inflammatory event (LPS-induced endotoxemia) can initiate the formation of key neuropathological hallmarks of AD (Aβ plaques and p-tau) in the brain. This suggests that systemic inflammation might be a significant contributing factor to neurodegenerative processes.
  • Neuroinflammation Precedes Plaque Formation: The study observed increased inflammatory cytokines and microglial activation before or concurrently with the significant increase in Aβ plaques, supporting the idea that neuroinflammation plays a crucial role in initiating or exacerbating Aβ pathology.
  • Diffuse Plaques as an Early Indicator: The Aβ plaques observed were characterized as "diffuse," meaning they had ill-defined margins and lacked dense cores. This morphology, along with their progressive increase over time, suggests they might represent an early stage of plaque development.
  • PET Tracer Utility: The increased uptake of [<sup>18</sup>F]flutemetamol in the cortex of LPS-treated rats, particularly the increased cortex:white matter ratio, validates the use of Aβ PET tracers as a tool to monitor Aβ plaque accumulation in response to inflammatory insults, both in animal models and potentially in humans.

Key Results

  • Elevated Cytokines: LPS administration led to significant increases in IL-1β, IL-6, and TNFα in both plasma and brain, indicating a robust systemic and secondary neuroinflammatory response. Brain IL-1β levels showed a particularly striking increase.
  • Increased Microglial Density: Cortical microglial density was significantly increased (1.9 times) in LPS-treated rats compared to controls at 24 hours post-injection.
  • Increased Soluble Aβ and p-tau: Soluble Aβ (1-42) levels in the brain peaked at 24 hours post-LPS (2 times higher than controls) and remained elevated. Phosphorylated tau (p-tau) content also doubled in LPS-treated rats compared to controls at 24 hours.
  • Progressive Aβ Plaque Formation: LPS-treated rats showed a progressive increase in the number of Aβ plaques in the cerebral cortex over the observation period (up to 7-9 days), with no plaques observed in control animals.
  • Increased PET Tracer Uptake: Three days post-LPS, there was a significant increase in [<sup>18</sup>F]flutemetamol uptake in the cortex of LPS-treated rats, and a significant increase in the cortex:corpus callosum ratio, suggesting increased Aβ plaque deposition.

Limitations and Future Work

  • Neurocognitive Significance: While the study demonstrates the formation of Aβ plaques and p-tau, the direct link to neurocognitive deficits in this specific model is not fully explored. The authors acknowledge that further neurocognitive studies are warranted.
  • Clearance of Pathology: It remains unknown whether the Aβ plaques and p-tau that form in response to LPS will eventually clear from the brain over time.
  • Human Confirmation: The study was conducted in rats, and further research is needed to confirm whether similar findings can be replicated in humans following sepsis or other systemic inflammatory conditions.
  • Topographical Mapping: A full mapping of the topographical and cell-associated distribution of Aβ plaques and p-tau, along with adjacent neurite morphology, needs to be performed.
  • Therapeutic Implications: The authors suggest that Aβ PET imaging could be used to evaluate the efficacy of potential therapies aimed at mitigating the neuroinflammatory consequences of sepsis.

Summary updated

Abstract

Amyloid beta (Aβ) plaques are not specific to Alzheimer's disease and occur with aging and neurodegenerative disorders. Soluble brain Aβ may be neuroprotective and increases in response to neuroinflammation. Sepsis is associated with neurocognitive compromise. The objective was to determine, in a rat endotoxemia model of sepsis, whether neuroinflammation and soluble Aβ production are associated with Aβ plaque and hyperphosphorylated tau deposition in the brain. Male Sprague Dawley rats received a single intraperitoneal injection of 10 mg/kg of lipopolysaccharide endotoxin (LPS). Brain and blood levels of IL-1β, IL-6, and TNFα and cortical microglial density were measured in LPS-injected and control animals. Soluble brain Aβ and p-tau were compared and Aβ plaques were quantified and characterized. Brain uptake of [<sup>18</sup>F]flutemetamol was measured by phosphor imaging. LPS endotoxemia resulted in elevations of cytokines in blood and brain. Microglial density was increased in LPS-treated rats relative to controls. LPS resulted in increased soluble Aβ and in p-tau levels in whole brain. Progressive increases in morphologically-diffuse Aβ plaques occurred throughout the interval of observation (to 7-9 days post LPS). LPS endotoxemia resulted in increased [<sup>18</sup>F]flutemetamol in the cortex and increased cortex: white matter ratios of activity. In conclusion, LPS endotoxemia causes neuroinflammation, increased soluble Aβ and Aβ diffuse plaques in the brain. Aβ PET tracers may inform this neuropathology. Increased p-tau in the brain of LPS treated animals suggests that downstream consequences of Aβ plaque formation may occur. Further mechanistic and neurocognitive studies to understand the causes and consequences of LPS-induced neuropathology are warranted.
BibTeX
@inproceedings{wang2018lipopolysaccharide,
  author = {Liming Wang and Qi Wu and Ryan A. Kirk and Kevin P. Horn and Ahmed Ebada Salem and John M. Hoffman and Jeffrey T. Yap and Joshua A. Sonnen and Rheal A. Towner and Fernando A. Bozza and Rosana Souza Rodrigues and Kathryn A. Morton},
  title = {{Lipopolysaccharide endotoxemia induces amyloid-β and p-tau formation in the rat brain.}},
  booktitle = {PubMed},
  year = {2018},
}
Figure